Vaccines represent 36.4% within the drug class segment and immunization accounts for 35.1% of the application category in 2025. The prefilled syringe drug molecule market was valued at USD 70.17 billion in 2024, is projected to reach USD 133.24 billion by 2035 and is forecast to post a 6.0% CAGR between 2025 and 2035.